By Ryan Davis ( June 4, 2018, 7:27 PM EDT) -- Regeneron has urged the U.S. Supreme Court to reverse a ruling that its patent for a genetically modified mouse is unenforceable due to inequitable conduct, saying the finding was wrongly based on misconduct during litigation and threatens to "wreak havoc" on the patent system....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.